# Becotatug Vedotin Plus Pucotenlimab and Capecitabine Followed by Concurrent Chemoradiotherapy-Immunotherapy for Locally Advanced Squamous Cell Carcinoma of the Anal Canal

> clinical trial · VERIFIED · 2026-09-02

Status: NOT_YET_RECRUITING · Sponsor: Wang Xin · Condition: Squamous Cell Carcinoma of the Anal Canal

- Company: Wang Xin
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07800000

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.